Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

5.08
+0.26005.39%
Post-market: 5.02-0.0620-1.22%19:52 EDT
Volume:1.42M
Turnover:7.05M
Market Cap:260.47M
PE:-1.50
High:5.11
Open:4.79
Low:4.75
Close:4.82
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:1.26
T/O Rate:2.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.76
PE(LYR):5.46

Loading ...

Emergent BioSolutions Secures New ACAM2000 Biodefense Contract

TIPRANKS
·
Jun 29

Emergent Gets $52.7 Million Contract Modification From US Government

MT Newswires Live
·
Jun 29

Emergent BioSolutions awarded $52.7M contract modification

TIPRANKS
·
Jun 29

Emergent Biosolutions Secures Contract Modification Valued at Approximately $52.7 Million for Acam2000® (smallpox and Mpox (vaccinia) Vaccine, Live) from the U.S. Government

THOMSON REUTERS
·
Jun 29

Emergent Biosolutions - Contract Modification Under Existing 10-year Contract with Aspr

THOMSON REUTERS
·
Jun 29

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

GlobeNewswire
·
Jun 04

Emergent BioSolutions awarded $64.5M HHS contract modification

TIPRANKS
·
May 29

BRIEF-Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy

Reuters
·
May 29

Emergent BioSolutions wins USD 64.5 million HHS contract modification for botulism antitoxin BAT

Reuters
·
May 29

Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

THOMSON REUTERS
·
May 29

Emergent BioSolutions to present at Jefferies Global Healthcare Conference

Reuters
·
May 20

Saudi regulator SFDA approves Emergent ACAM2000 vaccine for smallpox, mpox prevention

Reuters
·
May 18

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for Acam2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

THOMSON REUTERS
·
May 18

Press Release: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

TIPRANKS
·
May 02

Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

TIPRANKS
·
May 01

Emergent BioSolutions Q1 Revenue USD 156.1 Million

Reuters
·
May 01

Emergent BioSolutions Q1 Adj. EPS $0.21 Beats $(0.25) Estimate, Sales $156.100M Beat $145.000M Estimate

Benzinga Earnings
·
May 01

Emergent BioSolutions Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 01